Clinical Trial Update: DNR and AraC Combined to Fractionated Mylotarg® in Patients With First Relapse of AML [Phase 1, Phase 2]

View source ↗

Summary

This Phase 1/2 trial evaluated daunorubicin and cytarabine in combination with fractionated Mylotarg (gemtuzumab ozogamicin) in patients with first-relapse acut…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• CYTARABINE (CYTARABINE)
• Daunorubicin (daunorubicin)
• Mylotarg (gemtuzumab ozogamicin)

Snippet

Sponsor: Acute Leukemia French Association | Conditions: Acute Myeloid Leukemia | Phase 1, Phase 2 | Status: COMPLETED